Company: PCRX
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001396814-25-000102
Chunk: 35

Company: Pacira BioSciences, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 35
---
Item 1. FINANCIAL STATEMENTS (Unaudited)

PACIRA BIOSCIENCES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS 

(In thousands, except share and per share amounts)

(Unaudited)June 30,2025December 31,2024ASSETSCurrent assets:       Cash and cash equivalents$300,484 $276,774      Short-term available-for-sale investments145,380 207,841      Accounts receivable, net114,367 113,304      Inventories, net148,163 125,282      Prepaid expenses and other current assets37,219 21,929           Total current assets745,613 745,130 Fixed assets, net155,178 167,169 Right-of-use assets, net46,528 49,222 Goodwill20,300 — Intangible assets, net422,563 425,970 Deferred tax assets128,270 130,376 Investments and other assets18,810 35,649           Total assets$1,537,262 $1,553,516 LIABILITIES AND STOCKHOLDERS’ EQUITY  Current liabilities:       Accounts payable$30,124 $19,133      Accrued expenses71,023 80,124      Lease liabilities9,620 8,887      Current portion of convertible senior notes, net202,397 201,776           Total current liabilities313,164 309,920 Convertible senior notes, net280,267 279,334 Long-term debt, net97,828 104,211 Lease liabilities41,291 44,645 Contingent consideration17,209 20,241 Deferred tax liabilities4,583 — Other liabilities25,153 16,817           Total liabilities779,495 775,168 Commitments and contingencies (Note 16)Stockholders’ equity:  Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at June 30, 2025 and December 31, 2024— — Common stock, par value $0.001; 250,000,000 shares authorized; 47,690,595 shares issued and 44,897,